According to the sector presentation at the programme, where does India rank among global exporters of gems and jewellery?
- A.Third
- B.Fifth
- C.Eighth
- D.Twelfth
Correct answer
Explanation
The correct answer is eighth. The presentation by the Joint Director General of Foreign Trade at Jaipur placed India eighth among exporters of gems and jewellery worldwide, with a share of 2.9 per cent in a global market worth about one trillion dollars, and noted that the recently concluded agreements grant immediate duty-free access across tariff lines. Option A is wrong because it places India far higher than the stated rank. Option B is wrong for the same reason. Option D is wrong because it places the country lower than the position given in the presentation. The openings highlighted for the sector are worth noting as well: lab-grown diamond jewellery, coloured gemstones, Kundan-Meenakari heritage jewellery, smart and wearable jewellery, recycled gold jewellery, and pearl and cultured jewellery.
Read the full article: Commerce Dept Holds FTA Outreach for Exporters in Jaipur
Practice Questions
What were India estimated cumulative exports during April to September of 2026-27?
- A.US$ 418.31 billion
- B.US$ 476.20 billion
- C.US$ 512.60 billion
- D.US$ 389.75 billion
Show answer
This is the estimated cumulative figure for merchandise and services exports taken together during the first six months of the financial year.
Read the full explanation →In which city was the Leveraging FTAs outreach programme of the Department of Commerce held?
- A.Jodhpur
- B.Udaipur
- C.Jaipur
- D.Bhilwara
Show answer
The Department of Commerce organised the outreach programme in the Rajasthan capital to build awareness of the benefits available under India free trade agreements and to help exporters use them in practice.
Read the full explanation →Under which law has NPPA fixed the trade margin ceiling on these anti-cancer drugs?
- A.Paragraph 19 of the Drugs (Prices Control) Order, 2013
- B.Section 12 of the Essential Commodities Act
- C.Paragraph 4 of the National Pharmaceutical Pricing Policy
- D.Rule 65 of the Drugs and Cosmetics Rules
Show answer
This is the enabling provision cited by the regulator while capping the trade margin at thirty per cent of the Maximum Retail Price for the identified non-scheduled anti-cancer medicines.
Read the full explanation →From which date will the revised prices of the 137 anti-cancer drugs become effective?
- A.17 October 2026
- B.1 November 2026
- C.9 November 2026
- D.1 January 2027
Show answer
Retailers, chemists, hospitals and medical institutions have to charge the reduced prices from that day and must display the revised rates at their counters, while hospitals must also show them on their websites.
Read the full explanation →NPPA has capped the trade margin on 137 non-scheduled anti-cancer drugs at what share of the Maximum Retail Price?
- A.15%
- B.20%
- C.30%
- D.50%
Show answer
The National Pharmaceutical Pricing Authority has rationalised the trade margin on the identified non-scheduled anti-cancer medicines and held it to thirty per cent of the Maximum Retail Price, using the power given by Paragraph 19 of the Drugs (Prices Control) Order of 2013.
Read the full explanation →